AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34014692 — intervention group
Group type: COMPARATOR
Intervention: EVERYbody Project (dissonance-based body image intervention)
Number of subjects: 239
Study 33779506 — intervention group
Group type: EXPERIMENTAL
Intervention: Various docking software (Sybyl Surflex-Dock, OpenEye FRED, Hermes GOLD) with twelve different scoring functions.
Number of subjects: 0
Study 33779506 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-docking relaxation in Surflex.
Number of subjects: 0
Study 33779506 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical tools for screening and scoring functions.
Number of subjects: 0
Study 35545258 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (moderate intensity physical activity twice weekly at a centre and up to four times weekly at home, plus personalised nutritional counselling)
Number of subjects: 1519
Study 35545258 — intervention group
Group type: COMPARATOR
Intervention: Education on healthy ageing (control)
Number of subjects: 1519
Study 35545258 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1519
Study 35657084 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacutainer with cartoon characters
Number of subjects: 102
Study 35657084 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard bloodletting routine)
Number of subjects: 102
Study 34689841 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 97
Study 34689841 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone
Number of subjects: 97
Study 34689841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime cannabis and cocaine use disorders
Number of subjects: 97
Study 34689841 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 97
Study 32892609 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative venous computed tomographic angiography (CTA) combined with 3-dimensional computed tomography (3D CT)
Number of subjects: 63
Study 32892609 — intervention group
Group type: COMPARATOR
Intervention: Asterion for identification of the TSSJ (Control group)
Number of subjects: 63
Study 37286883 — intervention group
Group type: EXPERIMENTAL
Intervention: New sexual or physical victimization assessed 6 months after SAMFE via telephone interview.
Number of subjects: 233
Study 37286883 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of revictimization during follow-up.
Number of subjects: 233
Study 37286883 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted models for revictimization.
Number of subjects: 233
Study 33599561 — intervention group
Group type: EXPERIMENTAL
Intervention: National Swedish Kidney Cancer Register (NSKCR) reporting
Number of subjects: 431
Study 32350771 — intervention group
Group type: EXPERIMENTAL
Intervention: ED‐PrEP
Number of subjects: 54
Study 32350771 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily PrEP
Number of subjects: 54
Study 33902125 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria catalog 1
Number of subjects: 349
Study 33902125 — intervention group
Group type: EXPERIMENTAL
Intervention: Criteria catalog 2
Number of subjects: 349
Study 32598950 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal specialists
Number of subjects: 651
Study 32598950 — intervention group
Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA)
Number of subjects: 651
Study 32598950 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal specialists (for intraretinal fluid)
Number of subjects: 651
Study 32598950 — intervention group
Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA) (for intraretinal fluid)
Number of subjects: 651
Study 32598950 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal specialists (for subretinal fluid)
Number of subjects: 651
Study 32598950 — intervention group
Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA) (for subretinal fluid)
Number of subjects: 651
Study 34425875 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced assisted feedback
Number of subjects: 1797
Study 34425875 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic assisted feedback
Number of subjects: 1797
Study 34425875 — intervention group
Group type: COMPARATOR
Intervention: Simple feedback
Number of subjects: 1797
Study 34425875 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1797
Study 35550423 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 33
Study 35550423 — intervention group
Group type: COMPARATOR
Intervention: Traditional Debriefing
Number of subjects: 33
Study 34167637 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous posterior tibial nerve stimulation
Number of subjects: 408
Study 34167637 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 408
Study 35598359 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg bid)
Number of subjects: 386
Study 35598359 — intervention group
Group type: COMPARATOR
Intervention: Control (enzalutamide or abiraterone)
Number of subjects: 386
Study 33630641 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 138
Study 33630641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 138
Study 33630641 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 138
Study 33783254 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-plasticity computerized cognitive training
Number of subjects: 113
Study 33783254 — intervention group
Group type: COMPARATOR
Intervention: Active control group (computer games)
Number of subjects: 113
Study 33559050 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone Maintenance Treatment (MMT)
Number of subjects: 1255
Study 33559050 — intervention group
Group type: COMPARATOR
Intervention: Control group (5020 patients)
Number of subjects: 1255
Study 36273449 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic therapy
Number of subjects: 604
Study 36273449 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 days of antibiotic therapy
Number of subjects: 604
Study 36273449 — intervention group
Group type: COMPARATOR
Intervention: Nonincluded patients (control group)
Number of subjects: 604
Study 34261072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (HFNO) delivered by a portable device
Number of subjects: 20
Study 34261072 — intervention group
Group type: COMPARATOR
Intervention: Oxygen supplementation by a Venturi mask (Control)
Number of subjects: 20
Study 36243351 — intervention group
Group type: EXPERIMENTAL
Intervention: S. sonnei-rEPA vaccine (adults)
Number of subjects: 1857
Study 36243351 — intervention group
Group type: COMPARATOR
Intervention: Control vaccines (adults)
Number of subjects: 1857
Study 36243351 — intervention group
Group type: EXPERIMENTAL
Intervention: S. sonnei-rEPA conjugate (children)
Number of subjects: 1857
Study 36243351 — intervention group
Group type: EXPERIMENTAL
Intervention: S. flexneri 2a-rEPA conjugate (children)
Number of subjects: 1857
Study 32951998 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cardiothoracic surgery and liver transplantation (cCSLT)
Number of subjects: 1116
Study 32951998 — intervention group
Group type: COMPARATOR
Intervention: Isolated liver transplantation (iLT) - random
Number of subjects: 1116
Study 32951998 — intervention group
Group type: COMPARATOR
Intervention: Isolated liver transplantation (iLT) - matched
Number of subjects: 1116
Study 32649352 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban and aspirin
Number of subjects: 0
Study 32649352 — intervention group
Group type: COMPARATOR
Intervention: P2Y12 inhibition and aspirin
Number of subjects: 0
Study 35568940 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 3861
Study 34530881 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine administered every 18-24 hours, doses escalated daily (5-10 mg), for a minimum of 2 doses and a maximum of 5 doses (96 hours).
Number of subjects: 50
Study 34530881 — intervention group
Group type: COMPARATOR
Intervention: Sham catheter (control group) fixed like the intervention group but not entering the epidural space.
Number of subjects: 50
Study 32702001 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prescribed
Number of subjects: 35244
Study 32702001 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prescribed
Number of subjects: 35244
Study 32702001 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultations for UTI
Number of subjects: 35244
Study 32702001 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultations for skin infection
Number of subjects: 35244
Study 32702001 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultations for RTI
Number of subjects: 35244
Study 32702001 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely frail patients aged 55-64 years
Number of subjects: 35244
Study 35022859 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic vein embolisation
Number of subjects: 80
Study 35022859 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 80
Study 32342266 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of vitamin E on staple lines and anastomoses (G1)
Number of subjects: 140
Study 32342266 — intervention group
Group type: COMPARATOR
Intervention: Control group (G2) without vitamin E application
Number of subjects: 140
Study 34475360 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg twice daily for 7 days
Number of subjects: 97
Study 34475360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 34475360 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and Placebo (both groups)
Number of subjects: 97
Study 33186893 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic simulation (STOCH)
Number of subjects: 11
Study 33186893 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 11
Study 36317897 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term nutritional support for 1 month
Number of subjects: 0
Study 33929333 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence-focused guidance enhancement internet-based self-help intervention with social presence
Number of subjects: 775
Study 33929333 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence-focused guidance enhancement internet-based self-help intervention with impersonal service team
Number of subjects: 775
Study 33929333 — intervention group
Group type: COMPARATOR
Intervention: Internet as usual (control group)
Number of subjects: 775
Study 32130181 — intervention group
Group type: EXPERIMENTAL
Intervention: BCSMS app
Number of subjects: 112
Study 32130181 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112
Study 616840873 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet (60% carbohydrate, 20% fat, 20% protein)
Number of subjects: 21
Study 616840873 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (40% carbohydrate, 40% fat, 20% protein)
Number of subjects: 21
Study 616840873 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low carbohydrate diet (10% carbohydrate, 60% fat, 30% protein)
Number of subjects: 21
Study 616840873 — intervention group
Group type: COMPARATOR
Intervention: All diets
Number of subjects: 21
Study 33991416 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 7119
Study 33991416 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 7119
Study 32147485 — intervention group
Group type: COMPARATOR
Intervention: ACLR alone
Number of subjects: 618
Study 32147485 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR with lateral extra-articular tenodesis (LET)
Number of subjects: 618
Study 32147485 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR with LET
Number of subjects: 618
Study 36357602 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium:YAG laser enucleation of the prostate (ThuLEP)
Number of subjects: 110
Study 36357602 — intervention group
Group type: COMPARATOR
Intervention: Continuous-wave thulium fiber laser enucleation of the prostate (CW-ThuFLEP)
Number of subjects: 110
Study 32639254 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral, high frequency, dorsomedial prefrontal cortex (DMPFC) rTMS at 10 Hz, 120% of resting motor threshold, for 20 sessions.
Number of subjects: 29
Study 32639254 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (control group).
Number of subjects: 29
Study 34170241 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (PAP) spontaneous mode
Number of subjects: 32
Study 34170241 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 32
Study 33685834 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 147
Study 33685834 — intervention group
Group type: COMPARATOR
Intervention: Taxane
Number of subjects: 147
Study 35229407 — intervention group
Group type: EXPERIMENTAL
Intervention: MM-FAT (multimodal approach to food art therapy)
Number of subjects: 39
Study 35229407 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 39
Study 33852887 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 750
Study 33852887 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 750
Study 33852887 — intervention group
Group type: COMPARATOR
Intervention: Metabolic syndrome
Number of subjects: 750
Study 32319528 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYN 3 mg
Number of subjects: 0
Study 32319528 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYN 6 mg
Number of subjects: 0
Study 32319528 — intervention group
Group type: EXPERIMENTAL
Intervention: ZYN 8 mg
Number of subjects: 0
Study 32319528 — intervention group
Group type: COMPARATOR
Intervention: General 8 mg snus
Number of subjects: 0
Study 32319528 — intervention group
Group type: COMPARATOR
Intervention: Longhorn Natural 18 mg moist snuff
Number of subjects: 0
Study 32319528 — intervention group
Group type: COMPARATOR
Intervention: General 2 × 8 mg snus pouches
Number of subjects: 0
Study 35567304 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute alcohol condition
Number of subjects: 0
Study 35567304 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 0
Study 34323443 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.4 microgram/kg bolus followed by 0.4 microgram/kg/h infusion)
Number of subjects: 45
Study 34323443 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (Control group)
Number of subjects: 45
Study 34323443 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 45
Study 35425838 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal sparing whole-brain radiotherapy (HS-WBRT)
Number of subjects: 40
Study 35425838 — intervention group
Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 40
Study 34130725 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized protocol for structuring communication between clinicians in the OR and the ICU
Number of subjects: 12
Study 32709710 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia (brachial plexus block; 0.5% L-bupivacaine and 1.5% lidocaine with epinephrine)
Number of subjects: 126
Study 32709710 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia (0.5% L-bupivacaine and 1% lidocaine)
Number of subjects: 126
Study 32709710 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 126
Study 34813391 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV alternating with high-flow nasal oxygen
Number of subjects: 623
Study 34813391 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 623
Study 33434282 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Hyrax (HH) expander
Number of subjects: 40
Study 33434282 — intervention group
Group type: COMPARATOR
Intervention: Conventional Hyrax (CH) expander
Number of subjects: 40
Study 33027168 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty (HA)
Number of subjects: 1441
Study 33027168 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty (THA)
Number of subjects: 1441
Study 33027168 — intervention group
Group type: COMPARATOR
Intervention: Surgeons with no fellowship training
Number of subjects: 1441
Study 35471196 — intervention group
Group type: EXPERIMENTAL
Intervention: Be Well Plan program (5-week group-facilitated, internet-based intervention)
Number of subjects: 215
Study 35471196 — intervention group
Group type: EXPERIMENTAL
Intervention: Be Well Plan program
Number of subjects: 215
Study 35266409 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reduction (deprescribing antihypertensive medications)
Number of subjects: 0
Study 35266409 — intervention group
Group type: COMPARATOR
Intervention: Usual care (continuation of antihypertensive medications)
Number of subjects: 0
Study 33256659 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with fluoxetine, 20 minutes of 2 mA stimulation, three times per week for 8 weeks.
Number of subjects: 60
Study 33256659 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine only (sham control).
Number of subjects: 60
Study 35468601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 1817
Study 35468601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab 3 mg
Number of subjects: 1817
Study 35468601 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab
Number of subjects: 1817
Study 35468601 — intervention group
Group type: COMPARATOR
Intervention: Aflibercept 2 mg
Number of subjects: 1817
Study 34477854 — intervention group
Group type: EXPERIMENTAL
Intervention: ON101 cream (n = 122)
Number of subjects: 236
Study 34477854 — intervention group
Group type: COMPARATOR
Intervention: Absorbent dressing (n = 114)
Number of subjects: 236
Study 35783542 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian herbal medicine formula + routine treatment
Number of subjects: 82
Study 35783542 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 82
Study 32096138 — intervention group
Group type: EXPERIMENTAL
Intervention: Superelastic Nickel‐titanium shape memory (SNT) rods
Number of subjects: 0
Study 32096138 — intervention group
Group type: COMPARATOR
Intervention: Conventional Titanium (Ti) rods
Number of subjects: 0
Study 32096138 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chrome (Co‐Cr) rods
Number of subjects: 0
Study 34253671 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners examining patient records for harms, harm severity, and preventability.
Number of subjects: 9076
Study 32643211 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 180
Study 32643211 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SC)
Number of subjects: 180
Study 32643211 — intervention group
Group type: COMPARATOR
Intervention: Traditional Oral Health Education (TOHE)
Number of subjects: 180
Study 35272399 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided electroacupuncture at suprahyoid muscle group
Number of subjects: 120
Study 35272399 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture at Lianquan (CV 23), Wangu (GB 12) and Fengchi (GB 20)
Number of subjects: 120
Study 35272399 — intervention group
Group type: COMPARATOR
Intervention: Conventional electroacupuncture at suprahyoid muscle group
Number of subjects: 120
Study 33374033 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 16
Study 33374033 — intervention group
Group type: COMPARATOR
Intervention: Blister fluid (control)
Number of subjects: 16
Study 36371742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (non-opioid)
Number of subjects: 90
Study 36371742 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone-acetaminophen (opioid)
Number of subjects: 90
Study 33421333 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT)
Number of subjects: 30
Study 33421333 — intervention group
Group type: COMPARATOR
Intervention: Sham group (lowest pressure 5 cmH2O)
Number of subjects: 30
Study 32663820 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD) 12.5 mg once daily (QD)
Number of subjects: 160
Study 32663820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 35652533 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 37
Study 35652533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 37
Study 35652533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 37
Study 33665897 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in health/medical research
Number of subjects: 200
Study 33665897 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in randomized controlled trials of medications
Number of subjects: 200
Study 33665897 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective knowledge of research
Number of subjects: 200
Study 33665897 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits of research
Number of subjects: 200
Study 32799565 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic empagliflozin tablet (25 mg)
Number of subjects: 48
Study 32799565 — intervention group
Group type: COMPARATOR
Intervention: Brand-named empagliflozin tablet (Jardiance®) (25 mg)
Number of subjects: 48
Study 32799565 — intervention group
Group type: COMPARATOR
Intervention: High-fat food effect
Number of subjects: 48
Study 34537091 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery
Number of subjects: 0
Study 34537091 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative treatment
Number of subjects: 0
Study 35773718 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile device-based cognitive behavior therapy (CBT)
Number of subjects: 0
Study 35773718 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological treatments (Control group)
Number of subjects: 0
Study 34232202 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field therapy (3 mT and 10 Hz) for 30 minutes daily for 11 days
Number of subjects: 38